Hugh Lin
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
- Ocular Diseases and Behçet’s Syndrome
-
- Retinal Imaging and Analysis
- Retinal and Macular Surgery
Papers in
-
- Retinal Diseases and Treatments 9
- Retinal and Optic Conditions 3
-
- Angiogenesis and VEGF in Cancer 3
- Co-authors
- Balakumar Swaminathan (5 shared papers)Robyn H. Guymer (3 shared papers)David G. Silverman (6 shared papers)Daniela Ferrara (2 shared papers)Jeffrey R. Willis (4 shared papers)Charles C. Wykoff (3 shared papers)Carlos Quezada-Ruiz (5 shared papers)Karen Basu (5 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (5 papers)Survey of Ophthalmology (1 paper)Graefe s Archive for Clinical and Experimental Ophthalmology (1 paper)Ophthalmology (1 paper)Ophthalmology Science (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Hugh Lin
10 papers receiving 236 citations
Peers
Comparison fields: 5 of 27
- Ophthalmology 187
- Radiology, Nuclear Medicine and Imaging 83
- Molecular Biology 25
- Pharmaceutical Science 2
- Immunology 6
Countries citing papers authored by Hugh Lin
This map shows the geographic impact of Hugh Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Lin more than expected).
Fields of papers citing papers by Hugh Lin
This network shows the impact of papers produced by Hugh Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Lin. The network helps show where Hugh Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Hugh Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 62 | |
| 2 | 2021 | 60 | |
| 3 | 2021 | 46 | |
| 4 | 2019 | 45 | |
| 5 | 2023 | 17 | |
| 6 | Faricimab in Neovascular Age-Related Macular Degeneration: 1-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials | 2021 | 5 |
| 7 | Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): one-year results from the phase 3 YOSEMITE and RHINE trials | 2021 | 2 |
| 8 | Sustained Vessel Stabilization Through Targeting Angiopoietin-2 (Ang-2) With Faricimab, a Bispecific Antibody Neutralizing Both Ang-2 and Vascular Endothelial Growth Factor A (VEGF-A) | 2020 | 1 |
| 9 | Analysis of the serum and aqueous humor levels of IL-6 in patients with neovascular (wet) age-related macular degeneration (nAMD) receiving anti-vascular endothelial growth factor A monotherapy | 2018 | 1 |
| 10 | Clinical Effects of Blocking Ang-2 and VEGF with Faricimab in the Phase 2 STAIRWAY Trial | 2020 | 1 |
| 11 | Dual angiopoietin-2 and VEGF-A inhibition with faricimab in neovascular age-related macular degeneration: phase 3 TENAYA and LUCERNE trial design | 2021 | 0 |
About Hugh Lin
Hugh Lin is a scholar working on Ophthalmology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Surgery and Cardiology and Cardiovascular Medicine, having authored 11 papers that have together received 240 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (9 papers), Angiogenesis and VEGF in Cancer (3 papers), Retinal and Optic Conditions (3 papers), Retinal Imaging and Analysis (2 papers), Cell Adhesion Molecules Research (1 paper), Aortic aneurysm repair treatments (1 paper), Lipid metabolism and disorders (1 paper) and Protease and Inhibitor Mechanisms (1 paper). The work is most often cited by research in Ophthalmology (187 citations), Radiology, Nuclear Medicine and Imaging (83 citations), Molecular Biology (25 citations), Pharmaceutical Science (2 citations) and Immunology (6 citations). Hugh Lin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Balakumar Swaminathan, Robyn H. Guymer, David G. Silverman, Daniela Ferrara, Jeffrey R. Willis, Charles C. Wykoff, Carlos Quezada-Ruiz, Karen Basu, Karl G. Csaky and Aachal Kotecha. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Survey of Ophthalmology, Graefe s Archive for Clinical and Experimental Ophthalmology, Ophthalmology and Ophthalmology Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.